Camac Capital, LLC
SEC CIK 1867498 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | Member of 10% owner group | 1.64M | $26.4K | — | 1 | 2022-08-29 | 2022-08-29 |
Most active insiders at KTTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | STEINMAN LAWRENCE | Dir | $100.0K | — |
| 2 | Coastlands Capital LP | 10% | $53.0K | — |
| 3 | Dumesnil Simon | Dir | $25.0K | — |
| 4 | Marques Tiago | CEO, Dir | $25.0K | — |
| 5 | Leahy Emer | Dir | — | — |
| 6 | Schneiderman Daniel H | CFO | — | — |
Camac Capital, LLC made no open-market trades at KTTA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-08-31 | 2022-08-29+ | KTTA | Pasithea Therapeutics Corp. | Camac Capital, LLC | Member of 10% owner group | P - Purchase | $1.15 | +22.8K | 1.64M | +1% | +$26.4K |
Purchase Sale Sale after option exercise All abbreviations